tiprankstipranks
Trending News
More News >
United Therapeutics (UTHR)
NASDAQ:UTHR
US Market
Advertisement

United Therapeutics (UTHR) Ratios

Compare
673 Followers

United Therapeutics Ratios

UTHR's free cash flow for Q3 2025 was $0.87. For the 2025 fiscal year, UTHR's free cash flow was decreased by $ and operating cash flow was $0.55. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.40 4.41 9.85 7.61 6.70
Quick Ratio
6.07 4.28 9.55 7.30 6.44
Cash Ratio
2.45 1.50 2.80 2.93 2.28
Solvency Ratio
1.71 0.88 0.62 0.43 0.46
Operating Cash Flow Ratio
2.85 1.22 2.34 1.96 2.34
Short-Term Operating Cash Flow Coverage
0.00 2.44 0.00 0.00 0.00
Net Current Asset Value
$ 2.73B$ 2.37B$ 2.13B$ 1.11B$ 947.40M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.10 0.13 0.15 0.17
Debt-to-Equity Ratio
0.00 0.12 0.17 0.20 0.24
Debt-to-Capital Ratio
0.00 0.10 0.14 0.17 0.19
Long-Term Debt-to-Capital Ratio
0.00 0.05 0.14 0.17 0.19
Financial Leverage Ratio
1.12 1.20 1.26 1.31 1.36
Debt Service Coverage Ratio
53.99 2.39 25.22 33.26 22.22
Interest Coverage Ratio
61.46 19.98 30.24 29.89 25.26
Debt to Market Cap
0.00 0.07 0.06 0.08 0.12
Interest Debt Per Share
0.55 16.22 18.29 18.23 18.63
Net Debt to EBITDA
-0.79 -0.37 -0.15 -0.13 0.09
Profitability Margins
Gross Profit Margin
88.59%88.94%92.42%92.73%92.71%
EBIT Margin
53.65%57.30%51.08%40.75%40.21%
EBITDA Margin
54.55%59.58%53.73%43.71%43.57%
Operating Profit Margin
47.74%50.91%50.60%32.98%40.02%
Pretax Profit Margin
53.27%54.75%49.09%35.24%43.07%
Net Profit Margin
40.65%42.31%37.56%28.23%34.71%
Continuous Operations Profit Margin
40.65%42.31%37.56%28.23%34.71%
Net Income Per EBT
76.31%77.28%76.51%80.11%80.58%
EBT Per EBIT
111.58%107.54%97.03%106.84%107.63%
Return on Assets (ROA)
17.30%13.74%12.03%9.20%11.15%
Return on Equity (ROE)
18.83%16.46%15.16%12.02%15.16%
Return on Capital Employed (ROCE)
21.95%18.62%17.18%11.43%13.83%
Return on Invested Capital (ROIC)
16.75%13.54%13.15%9.16%11.14%
Return on Tangible Assets
17.58%13.96%12.12%9.28%11.55%
Earnings Yield
6.65%9.57%5.75%4.90%7.67%
Efficiency Ratios
Receivables Turnover
10.51 8.35 8.79 8.48 9.42
Payables Turnover
0.76 45.98 35.78 32.24 26.37
Inventory Turnover
2.02 2.30 1.44 1.31 1.25
Fixed Asset Turnover
2.01 2.23 2.25 2.16 2.03
Asset Turnover
0.43 0.32 0.32 0.33 0.32
Working Capital Turnover Ratio
1.00 0.80 0.77 0.87 0.91
Cash Conversion Cycle
-263.38 194.27 285.13 311.19 316.96
Days of Sales Outstanding
34.73 43.74 41.55 43.03 38.73
Days of Inventory Outstanding
180.51 158.47 253.78 279.49 292.07
Days of Payables Outstanding
478.62 7.94 10.20 11.32 13.84
Operating Cycle
215.24 202.21 295.33 322.51 330.80
Cash Flow Ratios
Operating Cash Flow Per Share
35.53 20.90 17.64 13.32 17.10
Free Cash Flow Per Share
25.61 15.97 14.59 10.63 15.76
CapEx Per Share
9.92 4.92 3.05 2.69 1.34
Free Cash Flow to Operating Cash Flow
0.72 0.76 0.83 0.80 0.92
Dividend Paid and CapEx Coverage Ratio
3.58 4.24 5.78 4.95 12.74
Capital Expenditure Coverage Ratio
3.58 4.24 5.78 4.95 12.74
Operating Cash Flow Coverage Ratio
0.00 1.40 1.00 0.75 0.94
Operating Cash Flow to Sales Ratio
0.50 0.42 0.41 0.35 0.51
Free Cash Flow Yield
5.75%7.26%5.25%4.92%10.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.03 10.45 17.40 20.39 13.03
Price-to-Sales (P/S) Ratio
6.23 4.42 6.53 5.76 4.52
Price-to-Book (P/B) Ratio
2.90 1.72 2.64 2.45 1.98
Price-to-Free Cash Flow (P/FCF) Ratio
17.38 13.77 19.06 20.32 9.63
Price-to-Operating Cash Flow Ratio
12.28 10.52 15.77 16.22 8.88
Price-to-Earnings Growth (PEG) Ratio
5.21 0.33 0.34 -2.26 -0.02
Price-to-Fair Value
2.90 1.72 2.64 2.45 1.98
Enterprise Value Multiple
10.64 7.05 12.01 13.04 10.48
Enterprise Value
18.17B 9.78B 12.49B 9.61B 6.77B
EV to EBITDA
10.65 7.05 12.01 13.04 10.48
EV to Sales
5.81 4.20 6.45 5.70 4.56
EV to Free Cash Flow
16.20 13.09 18.82 20.12 9.72
EV to Operating Cash Flow
11.68 10.00 15.57 16.06 8.96
Tangible Book Value Per Share
147.80 125.44 104.44 87.18 73.24
Shareholders’ Equity Per Share
150.46 127.88 105.42 88.17 76.81
Tax and Other Ratios
Effective Tax Rate
0.24 0.23 0.23 0.20 0.19
Revenue Per Share
71.42 49.73 42.56 37.54 33.56
Net Income Per Share
29.03 21.04 15.98 10.60 11.65
Tax Burden
0.76 0.77 0.77 0.80 0.81
Interest Burden
0.99 0.96 0.96 0.86 1.07
Research & Development to Revenue
0.17 0.18 0.17 0.32 0.24
SG&A to Revenue
0.14 0.17 0.21 0.24 0.25
Stock-Based Compensation to Revenue
0.04 0.02 0.06 0.08 0.11
Income Quality
1.22 0.99 1.10 1.26 1.47
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis